Eliem Therapeutics is a clinical-stage company developing medicines for patients with neurologic diseases. Our pipeline has two clinical stage compounds in conditions focused on pain, depression and epilepsy. The company continues to grow its preclinical pipeline in neurology. Eliem has funding from leading healthcare investors RA Capital, Access Biotechnology, and Bridge Valley Ventures. The company has locations in the Greater Seattle area of WA and Cambridge, UK.
Eliem Therapeutics Address
23515 NE Novelty Hill Road Redmond, WA United States